Stay updated with breaking news from Beth Weinman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Join Ropes & Gray's life sciences attorneys for a podcast series exploring regulatory, compliance, and enforcement changes emanating from Washington, D.C. and the potential impact on life sciences companies in 2024.
Welcome to the first installment of Ropes & Gray's new podcast series, Controlling Opinions, which is focused on current trends and developments related to controlled substances...
Hi, I'm Greg Levine, head of the life sciences regulatory and compliance practice group in Ropes & Gray's Washington, D.C. office.
This installation of Ropes & Gray’s podcast series Non-binding Guidance focuses on recent developments in FDA inspection policy, including…
Now that the U.S. Food and Drug Administration has released draft guidance and post-pandemic expectations for unapproved medical devices greenlighted under emergency use authorizations, manufacturers' next steps will depend on several factors, including device type and future intentions, say attorneys at Ropes & Gray.